Today: 4 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

PayPal dumps CEO Alex Chriss, taps HP chief Enrique Lores as earnings miss and dividend debut jolt stock

PayPal dumps CEO Alex Chriss, taps HP chief Enrique Lores as earnings miss and dividend debut jolt stock

PayPal named HP’s Enrique Lores as CEO, replacing Alex Chriss after weak Q4 results and a downbeat 2026 forecast sent shares tumbling 16% premarket. Jamie Miller becomes interim chief. Q4 revenue rose 4% to $8.7 billion, but branded checkout volume lagged. The board declared PayPal’s first quarterly dividend of $0.14, payable March 25.
Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma shares jumped 29.4% to $0.74 in premarket trading Tuesday after surging 64.6% to $0.94 in Monday’s after-hours session. The stock remains below the $1 minimum required for Nasdaq listing, with the company facing a July 14, 2026 deadline to regain compliance. Liminatus disclosed it received a Nasdaq deficiency notice in January. Market cap stood near $15.5 million.
3 February 2026
Las Vegas Sands stock near $56 before the bell as Macau gaming, dividend clock grab focus

Las Vegas Sands stock near $56 before the bell as Macau gaming, dividend clock grab focus

Las Vegas Sands shares held at $55.64 in Tuesday’s premarket after a 5.5% surge Monday. Macau’s January casino revenue jumped 24% year-over-year to $2.79 billion, outpacing forecasts. The stock goes ex-dividend Feb. 9, with a 30-cent payout set for Feb. 18. CEO Robert Goldstein received over 130,000 shares through vested awards last week, SEC filings show.
3 February 2026
TeraWulf (WULF) stock edges up premarket after Kentucky and Maryland power-site deals

TeraWulf (WULF) stock edges up premarket after Kentucky and Maryland power-site deals

TeraWulf shares rose 0.5% to $13.44 premarket after announcing two U.S. infrastructure acquisitions aimed at expanding bitcoin mining and high-performance computing. The Hawesville deal closed Feb. 2 for $200 million, with the seller taking a 6.8% stake in the data center project. The Morgantown acquisition awaits federal approval. TeraWulf’s infrastructure portfolio now totals about 2.8 GW across five sites.
Fusemachines stock jumps on IBM-partner deal — FUSE price action to watch before the bell

Fusemachines stock jumps on IBM-partner deal — FUSE price action to watch before the bell

Fusemachines shares fell 1.5% to $2.66 in premarket trading Tuesday after soaring 70.9% the previous session. The company announced a partnership with ModulAIre to deliver its AI Studio platform to enterprise clients using IBM systems. A filing showed Consilium Extended Opportunities Fund LP owns 13.61% of Fusemachines’ stock. Trading volume Monday exceeded 198 million shares.
3 February 2026
Sandisk stock price: why SNDK is moving again today after a 15% jump

Sandisk stock price: why SNDK is moving again today after a 15% jump

Sandisk shares rose 2.9% in premarket trading Tuesday after a 15.4% surge Monday, last changing hands at $684.17. The company reported fiscal Q2 revenue of $3.03 billion, up 61% year over year, and forecast Q3 revenue between $4.40 billion and $4.80 billion. Traders cited tight memory supply and AI-driven demand as key factors. Sandisk will report next earnings on April 29.
3 February 2026
Lumentum stock jumps into earnings day as LITE traders brace for after-bell report

Lumentum stock jumps into earnings day as LITE traders brace for after-bell report

Lumentum shares surged 8.1% Monday to $423.42 ahead of its fiscal Q2 earnings due after Tuesday’s close. Wall Street expects adjusted EPS of $1.40 and revenue near $646.7 million. Morgan Stanley raised its price target to $350 but kept an equal-weight rating. Investors are watching for signals on data-center demand and guidance during the 5 p.m. ET call.
Corning stock steadies before U.S. open after JPMorgan sticks with Overweight, insider sale disclosed

Corning stock steadies before U.S. open after JPMorgan sticks with Overweight, insider sale disclosed

Corning stock held near $110.36 in early Tuesday trading after a 6.9% surge Monday. JPMorgan reiterated its Overweight rating and $115 target, citing strong LCD panel trends. Retired president Eric Musser sold 25,000 shares Monday, leaving him with 19,926, according to an SEC filing. Meta’s multi-year deal with Corning, valued up to $6 billion, will expand fiber production in North Carolina.
3 February 2026
Brent price holds near $66 after Monday slide as OPEC+ stands pat and Iran talks loom

Brent price holds near $66 after Monday slide as OPEC+ stands pat and Iran talks loom

Brent crude recovered to $66.37 a barrel Tuesday after hitting a one-week low of $65.19, as traders weighed U.S.-Iran nuclear talks and OPEC+’s decision to keep March output steady. A new U.S.-India trade deal, requiring India to halt Russian oil purchases, added uncertainty to global crude flows. The dollar strengthened after Trump nominated Kevin Warsh as Fed chair. Russian officials said demand should rise in March and April.
3 February 2026
1 87 88 89 90 91 587

Stock Market Today

  • Howmet Aerospace's Defense Market Momentum Drives Revenue Growth
    June 4, 2026, 2:48 PM EDT. Howmet Aerospace Inc. (HWM) saw a 10% year-over-year revenue rise in Q1 2026, driven by strong demand in its defense aerospace sector, notably from the F-35 engine spares and legacy fighter jet parts. The Engine Products segment led with a 29% revenue increase. The 2026 Defense Appropriations Act bolsters this momentum through increased defense budgets. Peers like Honeywell and GE Aerospace also reported gains, with GE securing a $1.4 billion engine deal. HWM's shares surged 21.3% year-to-date, outperforming the industry. Despite trading at a high forward price-to-earnings ratio of 46.31X, earnings estimates for 2026 have risen by 9%. HWM holds a Zacks Rank #2 (Buy), supported by strong defense spending and geopolitical factors.

Latest articles

Palantir Stock Dips Despite Google AI News

Palantir Stock Dips Despite Google AI News

4 June 2026
Palantir shares fell 0.9% to $140.89 despite announcing a deeper Google Cloud partnership and new commercial deals at its AIPCon event, as investors weigh whether these moves will drive durable revenue growth amid ongoing valuation sensitivity, government-contract scrutiny, and shareholder pressure.
Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

4 June 2026
Grab Holdings’ U.S. shares jumped 2.9% to $3.51 as investors weighed strong Q1 results—revenue up 24% to $955 million, adjusted EBITDA up 46% to $154 million—and the consolidation of Indonesia’s Superbank, now majority-owned by Grab, against risks from higher fuel costs and regional regulation, leaving the stock sensitive to further updates on profitability and fintech growth.
Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs Jumps as Dow Sets New High

4 June 2026
Goldman Sachs shares surged 4.6% to $1,095.89, powering the Dow to an all-time high as investors rotated into financials; the move was amplified by Goldman’s high share price in the price-weighted Dow, while the bank’s lead role in the $75 billion SpaceX IPO and strong Q1 earnings added momentum, even as analysts flagged risks from high IPO valuations and geopolitical uncertainty.
Celsius Drops in New York After Texas Inquiry Hits Alani Nu Play

Celsius Drops in New York After Texas Inquiry Hits Alani Nu Play

4 June 2026
Celsius shares plunged 6.8% to near a 52-week low after Texas opened a probe into whether its Alani Nu drinks misled consumers about safety for minors, raising fresh legal and consumer-safety concerns just as the company relies on Alani Nu for growth and integration with PepsiCo’s distribution system.
Veru shares jump after Novo Nordisk deal draws traders

Veru shares jump after Novo Nordisk deal draws traders

4 June 2026
Veru shares soared 112% to $4.78 after announcing Novo Nordisk will supply Wegovy at no charge for Veru’s Phase 2b obesity trial, with Veru retaining global rights to enobosarm but granting Novo a right of first negotiation; analysts called the deal a “significant event” and kept $24–$25 targets, while Veru warned trial risks and reimbursement challenges remain.
Go toTop